N
NextCell Pharma AB
STO:NXTCL
NextCell Pharma AB
STO:NXTCL
Price:
1.28
SEK
1.11%
Market Closed
Market Cap:
kr142.6m
Income Statement
Earnings Waterfall
NextCell Pharma AB
NextCell Pharma AB
Income Statement
NextCell Pharma AB
NextCell Pharma AB
Currency: SEK
| Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
3
N/A
|
4
+29%
|
4
-1%
|
4
-5%
|
3
-9%
|
4
+17%
|
4
+3%
|
4
-1%
|
5
+34%
|
5
-12%
|
5
+16%
|
6
+4%
|
6
+14%
|
7
+13%
|
9
+20%
|
10
+17%
|
12
+21%
|
12
+2%
|
12
-5%
|
11
-10%
|
9
-13%
|
10
+10%
|
10
-2%
|
11
+10%
|
|
| Gross Profit | |||||||||||||||||||||||||
| Cost of Revenue |
(15)
|
(13)
|
(13)
|
(7)
|
(13)
|
(15)
|
(14)
|
(18)
|
(11)
|
(8)
|
(8)
|
(28)
|
(10)
|
(10)
|
(11)
|
(40)
|
(19)
|
(24)
|
(28)
|
(37)
|
(34)
|
(33)
|
(33)
|
(28)
|
|
| Gross Profit |
(12)
N/A
|
(10)
+22%
|
(10)
-1%
|
(3)
+67%
|
(10)
-202%
|
(12)
-20%
|
(10)
+15%
|
(15)
-46%
|
(6)
+60%
|
(4)
+34%
|
(3)
+30%
|
(22)
-733%
|
(3)
+84%
|
(2)
+31%
|
(2)
+11%
|
(30)
-1 286%
|
(7)
+77%
|
(12)
-74%
|
(16)
-40%
|
(26)
-63%
|
(25)
+5%
|
(23)
+10%
|
(23)
-1%
|
(17)
+26%
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(9)
|
(7)
|
(8)
|
(15)
|
(10)
|
(17)
|
(21)
|
(10)
|
(26)
|
(24)
|
(28)
|
(13)
|
(34)
|
(36)
|
(39)
|
(11)
|
(35)
|
(30)
|
(22)
|
(17)
|
(16)
|
(16)
|
(18)
|
(19)
|
|
| Selling, General & Administrative |
(9)
|
(7)
|
(7)
|
(8)
|
(8)
|
(11)
|
(13)
|
(10)
|
(13)
|
(11)
|
(12)
|
(13)
|
(13)
|
(14)
|
(15)
|
(15)
|
(16)
|
(17)
|
(17)
|
(16)
|
(15)
|
(15)
|
(15)
|
(16)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(7)
|
(1)
|
(5)
|
(8)
|
1
|
(12)
|
(13)
|
(16)
|
0
|
(20)
|
(22)
|
(23)
|
4
|
(19)
|
(12)
|
(5)
|
1
|
0
|
0
|
(0)
|
(0)
|
|
| Operating Income |
(22)
N/A
|
(17)
+21%
|
(17)
-1%
|
(18)
-2%
|
(19)
-10%
|
(29)
-49%
|
(30)
-6%
|
(25)
+19%
|
(31)
-26%
|
(28)
+11%
|
(31)
-11%
|
(35)
-13%
|
(38)
-7%
|
(39)
-4%
|
(41)
-5%
|
(41)
-1%
|
(42)
-3%
|
(40)
+4%
|
(38)
+6%
|
(43)
-13%
|
(41)
+5%
|
(39)
+4%
|
(41)
-3%
|
(36)
+12%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(22)
N/A
|
(17)
+21%
|
(17)
-1%
|
(18)
-2%
|
(19)
-10%
|
(29)
-48%
|
(30)
-6%
|
(25)
+19%
|
(31)
-26%
|
(28)
+11%
|
(30)
-10%
|
(35)
-13%
|
(37)
-7%
|
(38)
-3%
|
(40)
-4%
|
(40)
0%
|
(41)
-2%
|
(39)
+3%
|
(37)
+5%
|
(42)
-13%
|
(40)
+4%
|
(38)
+4%
|
(40)
-4%
|
(35)
+12%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(22)
|
(17)
|
(17)
|
(18)
|
(19)
|
(29)
|
(30)
|
(25)
|
(31)
|
(28)
|
(30)
|
(35)
|
(37)
|
(38)
|
(40)
|
(40)
|
(41)
|
(39)
|
(37)
|
(42)
|
(40)
|
(38)
|
(40)
|
(35)
|
|
| Net Income (Common) |
(22)
N/A
|
(17)
+21%
|
(17)
-1%
|
(18)
-2%
|
(19)
-10%
|
(29)
-48%
|
(30)
-6%
|
(25)
+19%
|
(31)
-26%
|
(28)
+11%
|
(30)
-10%
|
(35)
-13%
|
(37)
-7%
|
(38)
-3%
|
(40)
-4%
|
(40)
0%
|
(41)
-2%
|
(39)
+3%
|
(37)
+5%
|
(42)
-13%
|
(40)
+4%
|
(38)
+4%
|
(40)
-4%
|
(35)
+12%
|
|
| EPS (Diluted) |
-0.95
N/A
|
-0.75
+21%
|
-0.76
-1%
|
-0.8
-5%
|
-0.69
+14%
|
-0.91
-32%
|
-0.89
+2%
|
-0.56
+37%
|
-0.9
-61%
|
-0.81
+10%
|
-0.89
-10%
|
-0.79
+11%
|
-1.08
-37%
|
-1.11
-3%
|
-1.16
-5%
|
-0.91
+22%
|
-0.93
-2%
|
-0.89
+4%
|
-0.85
+4%
|
-0.57
+33%
|
-0.54
+5%
|
-0.52
+4%
|
-0.54
-4%
|
-0.32
+41%
|
|
Switch to:
Switch to:
See Also
Discover More
